Question 1

What weight loss medications does Regenics offer?

Accepted Answer

Regenics offers GLP-1 weight loss medications, both compounded and brand-name, prescribed based on your health history and clinical needs. These include compounded semaglutide and tirzepatide, as well as brand-name Ozempic and Wegovy when medically appropriate. All medications are prescribed by licensed Regenics providers and dispensed through licensed 503A U.S. pharmacies. Supportive add-ons including AOD-9604, lipotropic injections, and metabolic vitamins are also available.

Question 2

Does Regenics offer brand-name medications like Ozempic and Wegovy?

Accepted Answer

Yes. Regenics providers prescribe brand-name GLP-1 medications for patients seeking medicine for weight loss. Both Ozempic and Wegovy are available when medically appropriate. Wegovy, which contains semaglutide, is FDA-approved specifically for weight loss and is one of the most commonly prescribed weight loss medications in the country. Ozempic, also semaglutide, is FDA-approved for type 2 diabetes but is frequently prescribed as a weight loss medication when a licensed provider determines it's clinically appropriate. Your Regenics provider evaluates your health history and recommends the brand-name option that fits your needs and goals.

Question 3

How do weight loss injections work?

Accepted Answer

Semaglutide and tirzepatide work by acting like hormones your gut already releases after meals. These hormones trigger fullness signals in the brain, slow how quickly food leaves the stomach, and reduce the constant mental focus on food that many patients describe as food noise. Both medications are administered once weekly, delivered subcutaneously in the abdomen, thigh, or upper arm. GLP-1 medications produce a significant reduction in appetite and calorie intake without the hunger of traditional dieting. Dosing starts low and increases gradually every four weeks as your body adjusts.

Question 4

How much weight can I lose, and how quickly?

Accepted Answer

Semaglutide clinical trials show an average of 14.9% body weight loss over 68 weeks. Tirzepatide trials reach 20.2% on average over 72 weeks. Early tirzepatide results at three months show noticeably reduced appetite and visible scale changes for most patients. In real-world practice, patients typically lose 15 to 50 or more pounds depending on starting weight, medication, and consistency. A 20-pound loss on semaglutide is typically achievable within 10 to 16 weeks, with most patients seeing visible changes on the scale within four to eight weeks. Trial averages, not a promise. Your provider sets your dose based on how you respond.

Question 5

What dose of semaglutide or tirzepatide will I start on?

Accepted Answer

Semaglutide starts at 0.25mg weekly for four weeks, then increases gradually toward a maintenance dose of up to 2.5mg weekly. Tirzepatide starts at 2.5mg weekly and increases by 2.5mg increments every four weeks, with a maximum of 15mg weekly. Both medications follow a gradual escalation schedule designed to minimize side effects. Your Regenics provider walks you through the full dosing schedule during your consultation. The goal is the lowest effective dose that produces consistent results with manageable side effects.

Question 6

What are the most common side effects of GLP-1 medications?

Accepted Answer

The side effects of semaglutide and tirzepatide are similar and primarily gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Most patients feel some nausea and constipation in the first 4 weeks. It usually fades. If it doesn't, you message your provider. We can hold your dose, adjust, or prescribe an antiemetic. Some patients also experience mild fatigue or headaches during the first few weeks. Eating smaller, low-fat meals, staying hydrated, and avoiding alcohol can significantly reduce symptoms.

Question 7

What are the first signs that the medication is working?

Accepted Answer

Most patients notice the first signs that semaglutide or tirzepatide is working within one to three weeks of starting treatment. The experience is usually the same whether you're on Ozempic or Wegovy: appetite drops noticeably, portions feel smaller without effort, and the constant mental focus on food that many describe as food noise begins to quiet. Reduced hunger between meals is typically the earliest signal on Ozempic. Tirzepatide changes tend to appear on a similar timeline, sometimes faster given its dual-hormone mechanism. Semaglutide results at one month typically show visible changes on the scale for most patients. If appetite hasn't changed by week four, your Regenics provider evaluates whether a dose adjustment is appropriate.

Question 8

Do I need bloodwork or lab testing before starting a weight loss program at Regenics?

Accepted Answer

A blood panel is recommended before starting semaglutide or tirzepatide to confirm the medication is safe and appropriate for you. Regenics patients can complete lab testing at any Quest location across all 50 states. For patients visiting our Tarzana clinic, in-office lab testing and InBody body composition scans are also available. Blood panels assess key markers including hormones, metabolic function, blood sugar, and organ health, giving your Regenics provider a complete picture before prescribing. This level of clinical oversight is what separates a medical weight loss program from a standard online prescription service.

Question 9

Can GLP-1 medications be combined with other treatments at Regenics?

Accepted Answer

Yes. Regenics offers weight loss treatment options that go beyond GLP-1 medications alone. AOD-9604 peptide therapy is available for patients who want to accelerate fat burning through lipolysis and block the formation of new fat cells. Lipotropic injections with B vitamins support fat and carbohydrate metabolism as an additional layer to your program. TRT protocols are also available, since low testosterone is a common and frequently overlooked contributor to weight gain and metabolic slowdown. Regenics providers assess your full health picture and recommend the right combination for your needs.

Question 10

What happens if I stop semaglutide or tirzepatide?

Accepted Answer

Stopping GLP-1 medications abruptly can lead to increased appetite and gradual weight regain for some patients, especially if long-term nutrition and lifestyle habits haven't yet been established. Regenics providers help patients transition gradually whenever appropriate by tapering doses and focusing on sustainable habits. Some patients remain on maintenance dosing long-term. Others successfully taper off under medical supervision.

Lose weight on a GLP-1
protocol

What's your weight loss goal?

Lose 20% of your bodyweight

Brand-name and compounded GLP-1 medications

Semaglutide

Tirzepatide

Zepbound

Wegovy

Meet the providers on your team

Explore other weight loss products

Lipotropic

Ondansetron

Omeprazole

Hear about our patient's experiences

Frequently asked questions

Ready to get started?

Lose weight on a GLP-1 protocol